To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hallux Valgus Orthopedic Surgery

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 26, 2025

Primary Completion Date

December 27, 2025

Study Completion Date

December 27, 2025

Conditions
Postoperative Analgesia After Unilateral Hallux Valgus Correction Surgery
Interventions
DRUG

TRD205 tablets

Administered orally every 12 hours for a total of four times;Take TRD205 2 tablets and Placebo 4 tablets for the first time ,TRD205 1 tablets and Placebo 2 tablets each for the other three times.

DRUG

TRD205 tablets

Administered orally every 12 hours for a total of four times;Take TRD205 4 tablets and Placebo 2 tablets for the first time ,TRD205 2 tablets and Placebo 1 tablets each for the other three times.

DRUG

TRD205 tablets

Administered orally every 12 hours for a total of four times;Take TRD205 6 tablets and Placebo 0 tablets for the first time ,TRD205 3 tablets and Placebo 0 tablets each for the other three times.

DRUG

Placebo

Administered orally every 12 hours for a total of four times;Take Placebo 6 tablets for the first time ,Placebo 3 tablets each for the other three times.

Trial Locations (1)

102208

Beijing Jishuitan Hosapital, Beijing

All Listed Sponsors
collaborator

Beijing Jishuitan Hospital

OTHER

lead

Beijing Tide Pharmaceutical Co., Ltd

INDUSTRY